Life Sciences Lab Real Estate Rebounds, Opening Investor Opportunities
Life sciences lab real estate is clawing back from disaster, signaling renewed demand and potential opportunities for investors as the market stabilizes.
Tag
Life Sciences
All articles tagged with #life sciences
Dell Family Bets $750 Million on a New Life Sciences Hub
Philanthropists Michael and Susan Dell pledged $750 million to establish a life sciences hub, a landmark gift intended to accelerate biomedical research, biotech innovation, and related workforce development.
Dell Family Pledges Over $1B to Create AI-Driven Health Campus at UT Austin
Michael and Susan Dell committed more than $1 billion to UT Austin to establish the UT Dell Campus for Advanced Research and the UT Dell Medical Center, uniting medicine, life sciences and AI-enabled computing with MD Anderson as a partner. The gift funds undergraduate scholarships, housing, and the Texas Advanced Computing Center, positions Texas as a life sciences hub, and supports a broader $10 billion fundraising goal over 10 years; the medical center is slated to open in 2030 with groundbreaking planned this year.
OpenAI rolls out life sciences AI to speed drug discovery
OpenAI launches GPT-Rosalind, a life sciences-focused AI model designed to accelerate research in genomics and biochemistry by synthesizing evidence and generating hypotheses, while keeping humans in the loop; it features enterprise-grade security and is being rolled out in a research preview to trusted customers (e.g., Amgen, Moderna, Allen Institute, Thermo Fisher) to speed health outcomes and drug discovery without replacing scientists, amid concerns about misuse.
OpenAI Launches Life-Sciences AI to Rival Anthropic
OpenAI unveiled a life-sciences-focused AI model, GPT-Rosalind, aimed at the biopharma market and positioned to compete with Anthropic as tech giants push into pharma AI.
Blackstone closes record $6.3B life sciences fund, signaling biotech investment boom
Blackstone has closed a record $6.3 billion life sciences investment fund, the largest ever for a private fund in the sector, underscoring strong investor demand for biotech opportunities.
New Haven Secures $50.5M Investment to Boost Life Sciences and Quantum Tech
New Haven received a $50.5 million state grant to support the development of a new life sciences building, quantum computing initiatives, and pedestrian-friendly infrastructure, aiming to boost scientific research, job creation, and economic growth in the city.
Speeding Up Life Sciences Discoveries
OpenAI collaborated with Retro Bio to develop GPT‑4b micro, a specialized AI model for protein engineering, which has successfully accelerated research in stem cell reprogramming and DNA repair, demonstrating significant improvements over traditional methods and promising advancements in regenerative medicine.
Veeva Systems Surges After Earnings Beat and Analyst Upgrades
Veeva Systems' stock surged 22% after beating Q1 earnings forecasts and raising fiscal-year guidance, driven by strong financial results and expansion plans beyond the life sciences sector, though some analysts remain cautious due to industry pressures.
Danaher Corporation's Q3 Numbers Drive Stock Surge
Danaher Corporation reported its third-quarter 2023 results, with net earnings of $1.1 billion and revenues of $6.9 billion, representing a 10.5% decrease year-over-year. The company's non-GAAP adjusted diluted net earnings per common share were $2.02. Danaher's Biotechnology segment performed as expected, while higher respiratory testing revenue offset slightly softer demand in Life Sciences. The company also completed the spin-off of Veralto Corporation and provided its outlook for the fourth quarter and full year 2023, anticipating a decline in non-GAAP base business core revenue.
Thermo Fisher Scientific Acquires Olink in $3.1B Deal, Boosting Next-Generation Proteomics Leadership
Thermo Fisher Scientific has announced its plans to acquire Olink Holding AB in a $3.1 billion deal, aiming to enhance its life sciences portfolio and support drug discovery. The acquisition will provide Thermo Fisher's biotech customers with advanced protein analysis products and services, aiding in the acceleration of scientific breakthroughs. Olink's U.S.-listed shares surged by nearly 67% following the announcement, while Thermo Fisher's shares declined over 1%. The deal is expected to be completed by mid-2024 and will be funded through cash on hand and debt financing.
Thermo Fisher Scientific Expands Proteomics Portfolio with Olink Acquisition
Thermo Fisher Scientific, a global leader in scientific services, has announced its plan to acquire Olink Holding AB, a provider of next-generation proteomics solutions, for approximately $3.1 billion. The acquisition will enhance Thermo Fisher's capabilities in the high-growth proteomics market, complementing its existing life sciences and mass spectrometry offerings. Olink's proprietary technology, Proximity Extension Assay (PEA), enables rapid and efficient protein analysis, and the company has a library of over 5,300 validated protein biomarker targets. The transaction is expected to be completed by mid-2024, subject to regulatory approvals.
KKR Invests $3 Billion in Life Sciences Investor Catalio Capital
Private-equity firm KKR has acquired a minority stake in Catalio Capital Management, a firm specializing in venture-capital and other medical-investment funds. This move reflects a growing trend of private-equity firms entering the life sciences sector by partnering with earlier-stage investors, aiming to capitalize on emerging opportunities in biotechnology highlighted by the Covid-19 pandemic.
Dallas Secures Coveted ARPA-H Hub, Outshining Houston in Federal Health Research Initiative
Dallas has been chosen as one of the three headquarters for the Advanced Research Projects Agency for Health (ARPA-H), a federal biotech research agency with a $2.5 billion budget. The decision comes after months of campaigning by Texas cities, universities, and science advocates. The Dallas hub, located at Pegasus Park, will focus on customer experience, access, and diversifying clinical trials for ARPA-H projects. The Texas consortium also includes Austin, San Antonio, and Houston, with stakeholders in El Paso and College Station supporting the statewide team. The announcement also introduced ARPANET-H, a "hub and spoke" model that includes spoke sites across the country. This win solidifies Dallas' position as a major life sciences hub and is expected to bring jobs and economic development to the region.
Breakthrough Prize honors life-changing cystic fibrosis treatment and cancer pioneer with $3 million awards
The chemists behind the development of Trikafta, a triple-drug combination that has significantly improved the lives of people with cystic fibrosis, have been awarded the prestigious Breakthrough Prize. Sabine Hadida, Paul Negulescu, and Fredrick Van Goor at Vertex Pharmaceuticals developed the treatment by combining different drugs that help a faulty protein to function. Trikafta has been hailed as one of the most remarkable achievements in biomedical research in the last 30 years. The Breakthrough Prize, which awards achievements in life sciences, physics, and mathematics, also recognized breakthroughs in Parkinson's disease research, CAR-T-cell immunotherapy for leukemia, and the study of conformal field theories in physics.